Parnax Lab Limited (BOM:506128)

Market Cap	1.06B
Revenue (ttm)	1.85B
Net Income (ttm)	108.40M
Shares Out	11.49M
EPS (ttm)	9.43
PE Ratio	9.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,400
Average Volume	3,804
Open	92.75
Previous Close	94.90
Day's Range	91.25 - 97.00
52-Week Range	81.00 - 193.50
Beta	0.33
RSI	42.49
Earnings Date	May 30, 2025

About Parnax Lab

Parnax Lab Limited manufactures and sells pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; and medicinal products. It provides cosmetic products; herbal; and nutraceutical products. The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. The company was incorporated in 1982 and is headquartered in Mumbai, India.

• Industry: Pharmaceutical Preparations
• Founded: 1982
• Employees: 12
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506128

Financial Performance

In 2023, Parnax Lab's revenue was 1.89 billion, an increase of 12.65% compared to the previous year's 1.68 billion. Earnings were 96.09 million, an increase of 11.50%.